Beneficiaries will be able to self-register in advance by downloading Co-Win and also through other platforms such as Aarogya Setu
The states are Maharashtra, Kerala, Punjab, Karnataka, Tamil Nadu, and Gujarat
Gauba chaired a review meeting with chief secretaries of various states
Vaccinations in the next phase to begin on March 1
Experts on a second wave, contribution to global Covid research, vaccination programme takes a pause, and more-news relevant to India's fight against Covid-19
Noting that pandemic's impact on Gaza has been severe due to fragile health infra, India assured Palestine of providing second batch of medicines and an early supply of vaccines as covid assistance
After extending Covid-19 guidelines till March 31, Union Home Secretary Ajay Bhalla wrote to all states and UTs and said there is a need for maintaining caution to fully overcome the pandemic
The total number of global Covid-19 cases has topped 113 million, while the deaths have surged to more than 2.51 million, according to the Johns Hopkins University
Goa Chief Minister Pramod Sawant on Friday took cognisance of the rising number of Covid-19 cases and assured that he is monitoring the situation closely
President Joe Biden heard firsthand from Texans clobbered by this month's brutal winter weather on Friday
The UN Security Council on Friday unanimously passed a resolution calling on all member states to support a "sustained humanitarian pause" to local conflicts, in order to allow for Covid-19 vaccines
US regulators are working "rapidly" to finalise emergency use authorisation for a Johnson & Johnson vaccine which is on track to become America's third shot against the coronavirus pandemic which has killed 509,000 people in the last 12 months alone - the country's deadliest year.
Canada announced its approval of the use of the Covid-19 vaccine co-developed by the University of Oxford and AstraZeneca on Friday, clearing the way for millions of more inoculations in the country.
The process technology developed by the CSIR, IICT for the agonist molecule is playing an important role in the production of adjuvant for Bharat Biotech's COVID-19 vaccine Covaxin, the CSIR said
Serum Institute of India (SII) CEO Adar Poonawalla on Friday said he met Union Home Minister Amit Shah and apprised him about the ongoing COVID-19 vaccine rollout in the country. "It was my honour to brief you today, Shri Hon'ble @AmitShah Ji on the vaccine capabilities of our country and the ongoing rollout of vaccines in India," Poonawalla said in a tweet. In January, thecountry's drugs regulator had approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. Apart from making efforts to meet the requirements of India, SII, the world's largest vaccine maker, is also trying its best to balance the needs of the rest of the world.
Self-registration for the 60-plus group opens on March 1; service charge at private hospitals may be capped at Rs 100 per jab
In a Q&A, Dilip Jose says his chain of 16 hospitals currently is adopting a look-east, look-west policy to enhance its reach
Shipments to be made during second and third quarters of current calendar
Competition among poorer nations to get cheap or free vaccines to fight the pandemic had given China a golden chance to strengthen ties in emerging markets it has been courting for years
(Reuters) - A panel of expert advisers to the U.S. Food and Drug Administration began a meeting to discuss Johnson & Johnson's one-dose COVID-19 vaccine on Friday, setting the stage for a possible emergency use authorization as early as this week.